PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31465940-4	2019	The PFC nanoliposomes (FI@Lip) and biocompatible NO donor S-nitrosated human serum albumin (HSA-SNO) were combined to synergistically combat the obstacle of tumor micro-environment, reducing GSH concentration and increasing singlet oxygen (1O2) generation.	Altretamine	92-95	albumin	Homo sapiens	77-90	
31465940-4	2019	The PFC nanoliposomes (FI@Lip) and biocompatible NO donor S-nitrosated human serum albumin (HSA-SNO) were combined to synergistically combat the obstacle of tumor micro-environment, reducing GSH concentration and increasing singlet oxygen (1O2) generation.	Altretamine	92-95	strawberry notch homolog 1	Homo sapiens	96-99	
31465940-6	2019	In addition, with co-delivery of HSA-SNO, it can effectively promote GSH depletion to recover 1O2 level and release NO concurrently to inhibit mitochondrial respiration.	Altretamine	33-36	strawberry notch homolog 1	Homo sapiens	37-40	
31465940-7	2019	This combination strategy of FI@Lip and HSA-SNO obviously relieved intracellular hypoxia and decreased GSH to increase more toxic 1O2 generation for PDT enhancement.	Altretamine	40-43	strawberry notch homolog 1	Homo sapiens	44-47